European Funds Smart Growth Project

We are working on a Project devoted as a response to the COVID-19 pandemic situation. We are developing an autonomous analyzer that monitors the quality of hemodialysis treatment (extracorporeal dialysis) as a tool supporting the work of nephrologists in dialysis stations.

The developed technology will increase the safety of patients and enable the optimization of the duration of dialysis. It is particularly important under the current, strict sanitary and epidemiological regime, which, as expected, will not be abolished shortly.

Nephrologists currently face a challenging task – the complexity of procedures connected with the COVID pandemic forces them to look for solutions to reduce the duration of the process without limiting its effectiveness.

Such a task is practically impossible without analytical monitoring of the dialysis progress. The advantage of the technology will be the possibility of instant real-time acquisition of reliable data from many treatments. The monitoring system will allow the nephrologist to minimize the risk of contact with patients potentially infected with SARS-CoV-2. A statistical analysis of the duration of treatments concerning the actual progress in blood purification gives information about the effectiveness of the treatment in a given time. It allows for better management of the operating time of the dialysis station (the doctor may decide to shorten or extend a given dialysis session depending on the real need of the patient). Nowadays, the possibility of shortening dialysis duration is being considered for all patients. Patients should be protected against inadequate treatment, and it could be done thanks to the analytical assessment of the adequacy of the dialysis dose obtained by monitoring the procedure.

The technology developed within the Project will change the standards of treatment in a pandemic and post-pandemic situation.

We will offer our technology to the industrial partners after completing the industrial research and development phases of the Project:

  • Development of universal scheme of uremic toxin detection.
  • Development of a mathematical model of hemodialysis adequacy prediction.
  • Development of redundant and robust monitors of hemodialysis.
  • Construction and evaluation of demo series of monitors.
  • Integration of elements of the monitoring ecosystem and validation of monitoring devices.
  • Certification of the system to meet the medical device class II requirements.

Project co-financed by the European Union from the European Regional Development Fund under the Smart Growth Operational Program.

Project implemented as part of the National Centre for Research and Development call: Fast Track POIR.01.01.01-00-1213/20-00

The total value of the Project: PLN 8 833 113,75
The total value of funding: PLN 5 921 556,50